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ABSTRACT
Two multiplex PCR (mPCR) methods were developed to screen large collections of trimethoprim-
resistant Escherichia coli isolates for the most prevalent resistance determinants. Five common integron-
carried genes (dfrA1, dfrA5, dfrA7, dfrA12 and dfrA17) were selected as PCR targets. Primers and
conditions for standard mPCRs and real-time mPCRs were selected and tested. Two protocols using
essentially the same primer pairs were established. The standard mPCR protocol also included an
internal control targeting the E. coli 16S rRNA gene. Both protocols proved to be sensitive and speciﬁc
for detection of the ﬁve selected genes. Screening of three different collections of clinical urinary and
blood isolates (n = 368) with the two multiplex methods revealed that the ﬁve dfr genes accounted for
75–86% of trimethoprim resistance. The standard mPCR is useful and accessible for most laboratories,
while the real-time mPCR requires additional equipment and expensive reagents, but is very convenient
for high-throughput screening of large collections of bacterial isolates.
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INTRODUCTION
Trimethoprim resistance in clinically signiﬁcant
Gram-negative bacteria is usually caused by
horizontally transferable resistance genes (dfr
genes) coding for alternative resistant dihydro-
folate reductases. Most such genes can be found
as gene cassettes carried by integrons forming
parts of transposons, which mediate widespread
dissemination of trimethoprim resistance [1,2]. Of
31 known dfr genes, a few types seem to predom-
inate in most parts of the world. In a study of 90
dfr gene cassettes carried by class 1 integrons in
uropathogenic Escherichia coli isolates from 16
European countries and Canada, 36 were dfrA1,
eight were dfrA5, four were dfrA7, four were
dfrA12 and 28 were dfrA17, with no regional
correlation being apparent for this distribution
[3]. Furthermore, the same dfr types, except dfrA5,
were identiﬁed in 15 non-pathogenic trimetho-
prim-resistant E. coli isolates of food, animal and
human origin in Spain [4]. Similarly, studies of
gene cassette content in integrons from trimetho-
prim-resistant Gram-negative urinary isolates
from Sweden identiﬁed these ﬁve genes in 13 of
17 isolates, with two new dfr gene types being
found in two of the remaining isolates [5]. Other
small studies have also suggested that these ﬁve
genes appear to be the most widespread world-
wide [6–10].
Despite these observations, few studies have
investigated the distribution of dfr genes in large
bacterial collections, perhaps because of the
absence of a convenient and fast method for
screening for these genes. The number of dfr
gene types, both integron-associated and integ-
ron-independent, is growing constantly. Of the
known genes, some are very rare or seem to be
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geographically limited. Therefore, it can be
difﬁcult to decide which genes to screen for in
large collections of isolates. On the basis of
the above studies and personal experience, the
dfrA1, dfrA5, dfrA7, dfrA12 and dfrA17
genes were chosen for the development of
two multiplex PCR (mPCR) methods for screen-
ing large collections of trimethoprim-resistant
E. coli.
MATERIALS AND METHODS
Bacteria
Two different collections of bacterial isolates were used to
validate the two mPCRmethods developed. The ﬁrst collection
(designated UTI-Sto) comprised 105 Gram-negative urinary
isolates collected during 2001 by the Department of Clinical
Microbiology, Karolinska University Hospital, Stockholm,
Sweden, of which 71 were resistant to trimethoprim. Most
(n = 75) of these isolates were E. coli, while the remainder
belonged to various Gram-negative species, most of which
were other Enterobacteriaceae. The second collection (desig-
nated UTI-Vax) comprised 98 trimethoprim-resistant and 99
trimethoprim-susceptible E. coli urinary isolates collected
between June and October 2005 at the Department of Clinical
Microbiology, Central Hospital, Va¨xjo¨, Sweden. The UTI-Sto
isolates were used to determine the sensitivity of the PCR
assays, while the UTI-Vax isolates were used to determine the
speciﬁcity of the methods. A third collection (designated
Blood-Vax) comprised trimethoprim-resistant E. coli (n = 66)
isolates from blood cultures obtained during the last 20 years
at the Department of Clinical Microbiology, Va¨xjo¨, and was
used to further demonstrate the usefulness of the real-time
mPCR method.
Preparation of DNA templates for PCRs
All bacterial DNA templates used in PCRs were prepared by
boiling approximately three bacterial colonies suspended in
100 lL of sterile ﬁltered water (Sigma-Aldrich, Stockholm,
Sweden). The boiled samples were centrifuged brieﬂy and the
supernatants were used as DNA templates [5].
Single and standard mPCRs
Ampliﬁcation reactions (25 lL) contained 1 lL of DNA tem-
plate, PCR gold buffer (10 mM Tris-HCl, 50 mM KCl)
(Applied Biosystems, Stockholm, Sweden), 1.6 mM or
2.5 mM MgCl2 for the single and standard mPCRs, respec-
tively, 0.2 mM dNTPs, pH 7.5 (Amersham Biosciences,
Uppsala, Sweden), 0.5 lM each primer (Table 1), 0.6 U of
AmpliTaqGold (Applied Biosystems) and sterile ﬁltered water.
The primer concentration was doubled for primer dfr7&17-f in
the standard multiplex runs. The cycling program comprised
10 min at 95C, followed by 30 cycles of 45 s at 94C, 45 s at
50–60C and 2 min at 72C, with a ﬁnal extension for 10 min at
72C. The annealing temperatures used for the single PCRs
were as follows: dfrA1, 52C; dfrA5, 55C; dfrA7, 55C; dfrA12,
60C; and dfrA17, 55C. PCR products were detected by gel
electrophoresis (120 V for 40 min) in agarose (Amersham
Biosciences) 1% w ⁄v gels stained with ethidium bromide
5 mg ⁄L. The molecular size marker was number VIII (Roche
Diagnostics, Bromma, Sweden).
Real-time mPCRs
Reactions (20 lL) contained 1· QuantiTect SYBR Green PCR
Kit (Qiagen, Solna, Sweden), 0.3-0.6 lM each primer, RNAse-
free water (Qiagen) and 2 lL of template DNA. The real-time
PCRs were performed in a Rotor-Gene RG-3000 (Corbett
Research, Techtum Laboratory AB, Umea˚, Sweden) with
Rotor-Gene software v.6.0.25. Following optimisation, each
Table 1. Oligonucleotide primers
used for PCRs and sequence
analysis
Primer Locus
Sequence
(5¢ to 3¢)
Product
size (bp) Ref.
dfr1-f 5¢-dfr1 TGGTAGCTATATCGAAGAATGGAGT 425 This study
dfr1-r 3¢-dfr1 TATGTTAGAGGCGAAGTCTTGGGTA
dfr5-f 5¢-dfr5 AGCTACTCTTTAAAGCCTTGACGTA 341 This study
dfr5-r 3¢-dﬁr5 GTGTTGCTCAAAAACAACTTCG
dfr7&17-f 5¢-dfr7 and
5¢-dfr17
ACATTTGACTCTATGGGTGTTCTTC 280 This study
dfr7&17-r 3¢-dfr17 and
3¢-dfr7
AAAACTGTTCAAAAACCAAATTGAA
dfr7-r 3¢-dfr7 ACCTCAACGTGAACAGTAGACAAAT 227 with
dfr7&17-f
This study
dfr17-r 3¢-dfr17 TCTCTGGCGGGGGTCAAATCTAT 171 with
dfr7&17-f
dfr12-f 5¢-dfr12 GAGCTGAGATATACACTCTGGCACT 155 This study
dfr12-r 3¢-dfr12 GTACGGAATTACAGCTTGAATGGT
16s-f 5¢-16s GCGGACGGGTGAGTAATGT 200 [11]
16s-r 3¢-16s TCATCCTCTCAGACCAGCTA
dfr1s-f 5¢-dfr1 ATGGAGTGCCAAAGGTGAAC 241 This study
dfr1s-r 3¢-dfr1 TATCTCCCCACCACCTGAAA
dfr5s-f 5¢-dfr5 TCATTAATGGCTGCAAAAGC 460 This study
dfr5s-r 3¢-dfr5 CCTTTTGCCAAATTTGATAGC
dfr7s-f 5¢-dfr7 TCTGCAACGTCAGAAAATGG 404 This study
dfr7s-r 3¢-dfr7 TGCTCAAAAACCAAATTGAAA
dfr12s-f 5¢-dfr12 TTTATCTCGTTGCTGCGATG 457 This study
dfr12s-r 3¢-dfr12 TAAACGGAGTGGGTGTACGG
dfr17s-f 5¢-dfr17 GAAAATATCATTGATTTCTGCAGTG 465 This study
dfr17s-r 3¢-dfr17 TTTTTCCAAATCTGGTATGTATAATTT
Grape et al. Multiplex PCRs for dfr genes 1113
 2007 The Authors
Journal Compilation  2007 European Society of Clinical Microbiology and Infectious Diseases, CMI, 13, 1112–1118
reaction commenced with 15 min at 95C, followed by 40
cycles of 20 s at 94C, 20 s at 62C and 20 s at 72C, with a ﬁnal
30 s at 65C. A melt point analysis was performed after
completion of the 40 cycles using the FAM ⁄ sybr program
(source at 470 nm and detection at 510 nm) with measurement
of the ﬂuorescence at the end of each extension step. With two
exceptions (see Results), the same primers were used in the
real-time mPCR and the standard mPCR method (Table 1).
Controls
Positive controls for the dfrA1, dfrA5, dfrA7, dfrA12 and dfrA17
genes consisted of nine E. coli isolates and one Klebsiella
pneumoniae isolate with previously identiﬁed and sequenced
dfr genes, i.e., two isolates for each dfr type [5]. Primers speciﬁc
for an E. coli 16S rRNA gene [11] were included in the
standard mPCR as an internal control, but this was not
achievable for the real-time mPCR. Negative controls contain-
ing sterile ﬁltered water instead of DNA template were also
included in all batches of PCRs. In addition, all samples were
analysed twice with the mPCR protocols. If a discrepancy
between the two runs was observed, the assay was repeated a
third time.
DNA sequence analysis
PCR templates puriﬁed with a Jetquick spin column kit
(Genomed; Saveen Werner AB, Malmo¨, Sweden) were
sequenced using an ABI Prism Big Dye Terminator Cycle
Sequencing kit v.3.1 (Applied Biosystems) according to the
manufacturer’s instructions. Sequence analysis was performed
on an ABI Prism 3100 Genetic Analyzer (Applied Biosystems).
Subsequent nucleotide sequence analysis was performed using
Sequencher software v.4.1.4 (Gene Codes Corporation, Ann
Arbor, MI, USA) and the BLAST tool available from NCBI
(http://www.ncbi.nlm.nih.gov).
RESULTS
Single PCRs for the ﬁve dfr genes
Separate PCR assays were performed to detect the
presence in the UTI-Sto collection of isolates of the
ﬁve dfr genes selected for inclusion in the mPCRs.
The identities of the dfrA7 and dfrA17 genes were
conﬁrmed by two additional PCRs using the
speciﬁc primers dfr7&17-f, dfr7-r and dfr17-r
(Table 1). In total, 19 dfrA1, seven dfrA5, ﬁve
dfrA7, seven dfrA12 and 15 dfrA17 genes were
detected (Table 2). In total, 53 dfr genes were
detected in 71 trimethoprim-resistant isolates;
hence, the ﬁve genes were responsible for the
trimethoprim resistance in 75% of the isolates in
the UTI-Sto collection. The results of these ﬁve
single PCR experiments were taken as the refer-
ence standard against which all subsequent
assays were compared.
Standard mPCR for the ﬁve dfr genes
New primers were designed for the standard
mPCR, and several sets were tested to formulate a
PCR assay speciﬁc for the ﬁve selected dfr genes.
Twelve primers speciﬁc for the ﬁve genes and the
E. coli 16S rRNA gene [11] were included in the
reaction mixture. Following extensive method
development and optimisation, two standard
mPCR protocols were formulated. In the ﬁrst
standard mPCR method, the dfrA7 and dfrA17
genes could not be differentiated (these genes are
91% identical at the nucleotide level); thus dfrA7
and dfrA17 could only be differentiated by
sequence analysis. Subsequently, new primers
were designed for these two genes, which did
not interact with the remaining primers in the
PCR mastermix, and which yielded products that
were differentiated easily following gel electro-
phoresis. The ﬁnal protocol contained one com-
mon forward primer for both genes (dfr7&17-f),
one common reverse primer for both genes
(dfr7&17-r), and one reverse primer (dfr17-r)
speciﬁc for dfrA17. Consequently, isolates carry-
ing dfrA7 yielded two products, one 200-bp
Table 2. Results obtained using the reference standard (RS) single PCR, regular multiplex PCR (mPCR) and real-time
mPCR assays
Gene
UTI-Sto isolates
(n = 71)
UTI-Vax isolates
(n = 98 resistant isolates)
Blood-Vax isolates
(n = 66)
RS single PCR Regular mPCR Real-time mPCR Regular mPCR Real-time mPCR Real-time mPCR
dfrA1 19 (36%) 19 (36%) 19 (36%) 33 (39%) 33 (39%) 26 (50%)
dfrA5 7 (13%) 7 (13%) 7 (13%) 18 (21%) 18 (21%) 6 (12%)
dfrA7 5 (9%) 5 (9%) 5 (9%) 2 (2%) 2 (2%) 1 (2%)
dfrA12 7 (13%) 7 (13%) 7 (13%) 6 (7%) 6 (7%) 0
dfrA17 15 (28%) 15 (28%) 15 (28%) 26 (31%) 25 (30%) 19 (36%)
Total 53 (100%) 53 (100%) 53 (100%) 85 (100%) 84 (100%) 52 (100%)
Overall
percentage of
trimethoprim
resistance
75% 86% 79%
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amplicon for the positive control, and one 280-bp
amplicon corresponding to dfrA7. Isolates carry-
ing dfrA17 yielded an additional 170-bp amplicon
speciﬁc for dfrA17. Thus, the second standard
mPCR had the capacity to distinguish between all
ﬁve dfr genes, as well as the internal control gene,
without any requirement for sequence analysis.
The ﬁnal reagent concentrations used in this
method are listed in Table 3.
The UTI-Sto collection of isolates was analysed
with the second, more speciﬁc, mPCR, while both
mPCR protocols (with additional sequence analy-
sis) were used to screen the UTI-Vax isolates. The
standard mPCR identiﬁed 19 dfrA1, seven dfrA5,
ﬁve dfrA7, seven dfrA12 and 15 dfrA17 genes
among the UTI-Sto isolates, which was consistent
with the results obtained using the reference
standard method (Table 2). Analysis of the UTI-
Vax isolates using the ﬁrst protocol in combination
with sequence analysis identiﬁed 33 dfrA1, 17
dfrA5, two dfrA7, six dfrA12 and 25 dfrA17 genes.
With two exceptions, the same isolates were
positive for the same genes according to the
second protocol. One isolate was negative for all
ﬁve genes according to the ﬁrst protocol and
positive for dfrA5 according to the second proto-
col, and a second isolate was positive for dfrA1
according to the ﬁrst protocol and positive for
dfrA1 and dfrA17 according to the second protocol.
Overall, 85 dfr genes were detected in 84 of the
98 resistant isolates, and no dfr genes were
identiﬁed in the 99 susceptible isolates. Thus,
the ﬁve selected dfr genes accounted for the
trimethoprim resistance of 86% of the isolates
investigated. The amplicons were all clearly vis-
ible on the electrophoresis gels, and no faint or
non-speciﬁc bands were observed.
Real-time mPCR for the ﬁve dfr genes
Different annealing temperatures and primer con-
centrations were evaluated during the develop-
ment of the real-time mPCR. Two changes from
the standard mPCR protocol were required to
achieve optimal reaction conditions. First, the
primers for the internal control 16S rRNA gene
had to be removed, since the SYBR Green PCR
system does not allow reliable detection of more
than one PCR product from a single DNA sample.
Second, the common dfr7&17-r primer was
exchanged for the dfr7-r primer, which is speciﬁc
for dfrA7 only. This was possible because ampli-
con melt points are used for identiﬁcation instead
of product size. Mean amplicon melting temper-
atures were 81.6C for dfrA1, 85.3C for dfrA5,
78.1C for dfrA7, 83.3C for dfrA12, and 75.0C for
dfrA17. The ﬁnal reagent composition used in the
real-time mPCR is listed in Table 4.
The real-time mPCR method was used to
analyse both collections of urinary isolates. As
with the standard mPCRs, the same isolates were
positive for the same dfr genes, with the exception
of one isolate carrying two different dfr genes, for
which the real-time mPCR detected only one
gene, perhaps because competition between the
two amplicons in binding SYBR Green resulted in
disturbances in ﬂuorescence detection.
Sequence analysis of dfr genes
Sequence analysis was performed for 53 isolates
carrying dfr genes of all ﬁve types.
For all isolates positive for dfrA7 or dfrA17
(n = 27) in the UTI-Vax collection, the dfr type
Table 3. Final reagent concentrations used in the standard
multiplex PCR method with an optimal annealing tem-
perature of 60C
Reagents Final concentration
PCR gold buffer 10 mM Tris-HCl, 50 mM KCl
MgCl2 2.5 mM
dNTPs 0.2 mM
dfr1-f 0.5 lM
dfr1-r 0.5 lM
dfr5-f 0.5 lM
dfr5-r 0.5 lM
dfr7&17-f 1.0 lM
dfr12-f 0.5 lM
dfr12-r 0.5 lM
dfr7&17-r 0.5 lM
dfr17-r 0.5 lM
16s-f 0.5 lM
16s-r 0.5 lM
Taq polymerase 0.6 U
Table 4. Final reagent composition used in the real-time
multiplex PCR with an optimal annealing temperature of
62C
Reagents Final composition
2· QuantiTect SYBR Green PCR Kit 10 lL
dfr1-f 0.33 lM
dfr1-r 0.33 lM
dfr5-f 0.33 lM
dfr5-r 0.33 lM
dfr7&17-f 0.33 lM
dfr7-r 0.33 lM
dfr12-f 0.33 lM
dfr12-r 0.33 lM
dfr17-r 0.33 lM
Grape et al. Multiplex PCRs for dfr genes 1115
 2007 The Authors
Journal Compilation  2007 European Society of Clinical Microbiology and Infectious Diseases, CMI, 13, 1112–1118
was determined by sequence analysis of the entire
gene. The size of the sequenced amplicons was
465 bp for both dfrA7 and dfrA17, since the
primers targeted sequences that were identical
in both genes. Primers used for the reference
standard single PCR method were used for
ampliﬁcation of DNA template and as primers
for sequence analysis. The sequences obtained for
two dfrA7 and 25 dfrA17 genes, respectively, were
almost identical, differing at most by four nucle-
otide bases, and matched exactly with several
published sequences in the EMBL ⁄NCBI databas-
es for these two dfr genes.
In the UTI-Vax collection of isolates, the ﬁrst
ten amplicons identiﬁed as dfrA1 and dfrA5, and
all six dfrA12 amplicons were also sequenced to
validate the speciﬁcity of the method. The primers
from the reference standard method were used
for ampliﬁcation and sequencing, except for the
dfrA1 amplicons, for which the multiplex primers
were used to achieve a larger product. Sequence
analysis revealed that all three genes had been
identiﬁed correctly by the multiplex PCRs, with
no differences in the nucleotide sequences ob-
tained, with the exception of 3 bp for dfrA1. The
sequences obtained for these three genes were
identical to a large number of sequences con-
tained in the EMBL ⁄NCBI databases.
Sensitivity and speciﬁcity
The sensitivity of the second standard mPCR
protocol was 100% in comparison with the
reference standard method used to examine the
UTI-Sto isolates. For the UTI-Vax isolates, the
ﬁrst and second standard multiplex protocols
yielded the same results, except that the second
protocol detected two additional genes. When
the real-time mPCR was compared with the
reference standard method for the UTI-Sto iso-
lates, and with the regular protocol for the UTI-
Vax isolates, the sensitivity was 100% and 99%,
respectively, with the lower ﬁgure explained by
the inability to detect two concurrent genes in
the same isolate.
The speciﬁcity of both the standard mPCR and
the real-time mPCR methods was 100%. No dfr
genes were detected in the 99 trimethoprim-
susceptible isolates, and no false-positive results
were revealed by sequence analysis of 54 dfr genes
detected among the UTI-Vax isolates, or in the
comparison of results obtained with the regular
and real-time protocols for any of the isolates.
Thus, although these isolates may harbour other
dfr genes or trimethoprim resistance mechanisms,
the methods described in the present study are
speciﬁc and do not detect dfr genes other than the
ﬁve selected for the study.
Use of real-time mPCR for screening E. coli
isolates from blood cultures
The fast and user-friendly real-time mPCR proto-
col was used to screen 66 trimethoprim-resistant
E. coli isolates from blood cultures for the ﬁve dfr
genes. Of these isolates, 52 carried one of the ﬁve
dfr genes, comprising 26 dfrA1, six dfrA5, one
dfrA7 and 19 dfrA17 genes, accounting overall for
79% of the trimethoprim resistance observed in
these isolates.
DISCUSSION
This study describes the development of two
alternative mPCR methods for the detection of
ﬁve of the most common dfr genes causing
trimethoprim resistance in E. coli. The results
obtained from testing the methods with a mixed
collection of Gram-negative bacteria indicate that
these genes are present in most Gram-negative
bacteria, and most probably in all members of
the Enterobacteriaceae, since dfr genes are com-
monly found as integron gene cassettes in all of
these species. The two mPCR protocols formed
robust, sensitive and speciﬁc detection methods
for the ﬁve selected genes, and yielded almost
identical results with two different collections of
bacterial isolates, despite the fact that some of
the dfr genes are very closely related, e.g., dfrA7
and dfrA17.
The development of two equally reliable meth-
ods, using essentially the same set of primers and
reaction conditions, makes it possible to choose
the method most suitable for particular laboratory
conditions. The aim was to make these methods
as simple as possible; thus, boiling was used for
DNA template preparation rather than expensive
kits and robots. The standard mPCR protocol can
be performed conveniently in most laboratory
environments, while the real-time mPCR requires
more advanced and expensive equipment and
reagents. However, the latter approach makes the
screening of large collections of bacteria for
speciﬁc trimethoprim resistance genes even more
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feasible. The real-time mPCR is quicker, as DNA
ampliﬁcation and melt point analysis requires
only 1.5 h.
Initially, primers optimal for the detection of
each gene were tested separately with the UTI-Sto
collection of isolates. Since the results agreed with
the subsequent results using the two mPCR
methods, it is probable that these results reﬂect
the true frequency of dfr genes in the UTI-Sto
collection. One advantage of the standard mPCR
protocol is the inclusion of an internal control that
detects the E. coli 16S rRNA gene. With this
control, the integrity of the DNA template can be
assured, although no false-negative results caused
by an inadequate template were observed. Unfor-
tunately, the real-time protocol did not allow the
inclusion of an internal control. External controls,
in the form of isolates positive for each of the genes
that the method was designed to detect, cannot
replace an internal control, but were always
included as controls for each batch of reaction
mixtures.
Another drawback with a real-time mPCR
utilising SYBR Green detection is that it is not
possible to reliably identify multiple dfr genes in
the same isolate. However, it is a rare occurrence
for isolates to carry more than one of the ﬁve dfr
genes studied, and this limitation can probably be
accepted after taking into consideration the time
saved.
The frequencies of the ﬁve genes were compa-
rable in the two collections of urinary isolates
used for validation (Table 2). In the UTI-Sto
collection of mixed Gram-negative isolates, 75%
of the trimethoprim-resistant isolates carried one
of the ﬁve dfr genes studied, with a predominance
of dfrA1 and dfrA17. In the UTI-Vax collection,
consisting of only trimethoprim-resistant E. coli,
86% of the resistance was conferred by one of the
ﬁve dfr genes. These results are broadly in line
with a large European–Canadian study, in which
108 (66%) of 163 trimethoprim-resistant isolates
carried a class 1 integron with one of these ﬁve dfr
genes as an inserted gene cassette [3]. When the
third collection of 66 consecutive trimethoprim-
resistant E. coli blood culture isolates collected
during the last 20 years was screened with the
real-time mPCR method, the results also indi-
cated that most of the resistance was caused by
dfrA1 and dfrA17. The complete absence of dfrA12
genes was somewhat unexpected, although this
gene has not been very prevalent in previous
studies.
In conclusion, both mPCR methods proved to
be useful tools for detection of the most pre-
valent trimethoprim resistance genes, namely
dfrA1, dfrA5, dfrA7, dfrA12 and dfrA17 [3–10].
This is especially important in the case of
trimethoprim, since there are no phenotypic
methods to indicate which particular gene is
conferring resistance. Variations in dfr gene
distribution may occur as a result of changes in
the selective pressure, and screening of this type
would provide a sensitive and convenient
method for detecting possible changes in the
prevalence of different dfr genes.
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